Related Experiment Video
Updated: Jul 11, 2026

Preclinical Model of Prenatal Delta-9-Tetrahydrocannabinol Exposure to Assess Its Impact on Neurodevelopmental Outcomes
Published on: February 28, 2025
Marihuana: A Conversation with NIDA's Robert L. DuPont
Abstract:
Robert L. DuPont, director of the National Institute on Drug Abuse (NIDA), made headlines recently when he became one of the first Administration officials publicly to recommend a liberalization of marihuana laws. The occasion was a press conference accompanying the release of Marihuana and Health, NIDA's fifth annual report to the Congress on marihuana research. Recently, Science talked with DuPont and asked him to elaborate on those views. DuPont, a 40-year-old Harvard M.D., served as Director of the District of Columbia's Narcotics Treatment Administration from 1970 to 1973, where he conducted a comprehensive program for treatment of heroin addiction. In June 1973, Richard Nixon appointed him director of the White House Special Action Office for Drug Abuse Prevention. He held that position until the office was terminated on 30 June 1975. He has been director of NIDA since September 1973.
Related Concept Videos
Chemotherapy-Induced Nausea and Vomiting: Cannabinoids
Two synthetic agonists of THC,...
Hallucinogens and Psychedelics
Marijuana, derived from the dried leaves and flowers of the hemp plant, contains delta-9-tetrahydrocannabinol (THC)...
An Overview of Psychoactive Drugs
Stimulants such as cocaine, amphetamines, and nicotine enhance brain activity, leading to increased alertness, attention, and energy. These drugs typically raise heart rate, blood pressure, and body temperature. While they can induce feelings of euphoria, their misuse can result in severe health...
Altered States of Awareness
The ingestion of substances like stimulants or hallucinogens leads to chemical alterations in the brain that...
CNS Stimulants: Cocaine, Amphetamines and Cannabinoids
Drug Regulation

